| Toggle Summary
|
PRO-PHARMACEUTICALS EXPANDS PATENT PORTFOLIO WITH NEW PATENTS IN THE U.S. AND AUSTRALIA
Patents Cover Use of DAVANAT® with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS REPORTS FULL YEAR and FOURTH QUARTER 2010 FINANCIAL RESULTS
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT BIO CEO & INVESTOR CONFERENCE
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS CLOSES $2.1 MILLION OFFERING
Warrant Exercises Generate Additional $1 Million
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT SAN FRANCISCO BIOTECH CONFERENCE
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS EXPANDS PATENT COVERAGE TO AUSTRALIA
Patent Covers Use of DAVANAT® with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments
|
View HTML
|
| Toggle Summary
|
PRO-PHARMACEUTICALS REPORTS THIRD QUARTER 2010
|
View HTML
|
